Username Password
S&P 500: 1,317.45 Change: +0.03%

CLEVELAND BIOLABS INC (CBLI)

Overview
Price 1.30
Price Change Today +$0.09 (+7.44%)
P&P rating Rating: 5
Zacks Rank 3 - HOLD
Open Price $1.20
Previous Close $1.21
Daily Range $1.20 - $1.32
52-Week Range $1.15 - $5.71
Volume 147,219
chart
CLEVELAND BIOLABS, INC. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute. The Company's proprietary technology platform is based on the ability to suppress or stimulate programmed cell death (apoptosis). CBLI's drugs can switch apoptosis on and off by affecting key regulators of cell response to stresses, such as radiation or ischemia. CBLI is pursuing three key areas of research: Biodefense for Acute Radiation Syndrome, Cancer Treatment, and Tissue Protection.
Other Resources for CBLI
zacks.com
Commentary
Zacks Blog: Zacks #5 Rank Additions for Monday
June 20, 2011
CLEVELAND BIOLABS, INC. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute. The Company's proprietary technology platform is based on the ability to suppress or stimulate programmed cell death (apoptosis). CBLI's drugs can switch apoptosis on and off by affecting key regulators of cell response to stresses, such as radiation or ischemia. CBLI is pursuing three key areas of research: Biodefense for Acute Radiation Syndrome, Cancer Treatment, and Tissue Protection.
 
Brokerage Analyst Recommendations
1 Brokerage Firms Covering CBLI
 
 
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1
 
CBLI Ratings:BUY  SELL  HOLD
CBLI Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

6 Buy
0 Sell
 
Top Buy Analysis
BUY: CBLI Rating: 5
Company: CLEVELAND BIOLABS INC.
Points: -91.58
Start Price: $6.05
Start Date: 10/08/2010 4:46 PM
hangash
hangash
P&P Score: 0.57
Recs:
cbli is developing late stage treatement product for peaple suffering radiation exposure. The us defense department and otther entities such as russian federation, south africa among others are lining up to order this product. please see company website for further insight.

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
No related Blog Posts.
Commentary
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $6.05
Points: -91.58
Created: 10/08/2010
cbli is developing late stage treatement product for peaple suffering radiation exposure. The us defense department and otther entities such as russian federation, south africa among others are lining up to order this product. please see company website for further insight.

Comments: 0 | Comment

Recs:
 
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $10.56
Points: -77.44
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $7.52
Points: -72.46
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $9.64
Points: -76.26
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $8.60
Points: -74.63
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CLEVELAND BIOLABS INC. (CBLI) Rating: 5
Start Price: $12.50
Points: -79.35
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
hangash 0.57 BUY Week or Less 10/08/2010 $6.05 $1.30
(+7.44%)
-78.51% +13.07% -91.58 view
Chadn 33.67 BUY Six Months to a Year 01/01/2008 $10.56 $1.30
(+7.44%)
-87.69% -10.25% -77.44
foolish8baron 62.65 BUY Six Months to a Year 01/01/2008 $7.52 $1.30
(+7.44%)
-82.71% -10.25% -72.46
melvinB20 46.21 BUY Six Months to a Year 01/01/2008 $9.64 $1.30
(+7.44%)
-86.51% -10.25% -76.26
SureAndEasy 58.59 BUY Six Months to a Year 01/01/2008 $8.60 $1.30
(+7.44%)
-84.88% -10.25% -74.63
Labrat BUY Six Months to a Year 01/01/2008 $12.50 $1.30
(+7.44%)
-89.60% -10.25% -79.35
Sponsored Links